Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 54

ScienceDirect

Venetoclax is a highly selective B-cell lymphoma-2 (BCL-2) inhibitor, which, combined with a DNA hypomethylating agent or low dose cytarabine,